Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator

AIMS: Fingolimod is a sphingosine‐1‐phosphate (S1P) receptor modulator approved for the treatment of the relapsing form of multiple sclerosis (MS). It prevents the egress of lymphocyte subpopulations from lymphoid tissues into the circulation. Here, we explored the broad effects of fingolimod on gen...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:CNS Neurosci Ther
Hoofdauteurs: Angerer, Ines C., Hecker, Michael, Koczan, Dirk, Roch, Luisa, Friess, Jörg, Rüge, Annelen, Fitzner, Brit, Boxberger, Nina, Schröder, Ina, Flechtner, Kristin, Thiesen, Hans‐Jürgen, Winkelmann, Alexander, Meister, Stefanie, Zettl, Uwe K.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2018
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490155/
https://ncbi.nlm.nih.gov/pubmed/29314605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12793
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items